BEATRICE ST CLAIRE: Open Payments
NPI 1518041144 · MODESTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$645 in 37 payments from 9 companies in 2025. Trend: 2023 $428 · 2024 $626 · 2025 $645
Food & beverage: $645
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 17 | $229 |
| Otsuka America Pharmaceutical, Inc. | 9 | $149 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $85 |
| Janssen Pharmaceuticals, Inc | 2 | $58 |
| ABBVIE INC. | 2 | $38 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
Products named: ARISTADA, CAPLYTA, ABILIFY MAINTENA, REXULTI, INVEGA SUSTENNA, VRAYLAR, INGREZZA, UZEDY.
Industry payments across CA — which companies pay providers there.
